BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28934901)

  • 1. Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
    Chen G; Wu SQ; Feng M; Wang Y; Wu JC; Ji GY; Zhang MM; Liu QQ; He JQ
    Int J Immunopathol Pharmacol; 2017 Dec; 30(4):434-438. PubMed ID: 28934901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
    Xiang Y; Ma L; Wu W; Liu W; Li Y; Zhu X; Wang Q; Ma J; Cao M; Wang Q; Yao X; Yang L; Wubuli A; Merle C; Milligan P; Mao Y; Gu J; Xin X
    PLoS One; 2014; 9(1):e85905. PubMed ID: 24465778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury.
    Wu S; Wang Y; Zhang M; Wang M; He JQ
    Therapie; 2019 Jun; 74(3):399-406. PubMed ID: 30093157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LEPR polymorphisms with predisposition and inflammatory response in anti-tuberculosis drug-induced liver injury: A pilot prospective investigation in Western Chinese Han population.
    Zhao Z; Peng W; Zhou J; Zhou Y; Liu T; Bai H; Wu Q; Song J; Wu L; Song X; Ying B
    Infect Genet Evol; 2019 Nov; 75():103970. PubMed ID: 31325611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of significant association between UGT2B4 genetic variants and the susceptibility to anti-tuberculosis drug-induced liver injury in a Western Chinese population.
    Chen H; Jiao L; Zhou J; Bai H; Lyu M; Wu T; Wu L; Song J; Liu T; Yan H; Ying B
    J Clin Pharm Ther; 2021 Feb; 46(1):66-73. PubMed ID: 32170986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
    Ji GY; Wang Y; Wu SQ; Liu QQ; Wu JC; Zhang MM; Sandford AJ; He JQ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
    Wang Y; Xiang X; Wu SQ; Chen G; Zhang MM; Wang MG; Wang FJ; Sandford AJ; He JQ
    Infect Genet Evol; 2017 Jul; 51():198-202. PubMed ID: 28389387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
    Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
    J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.
    Tao B; Yang M; Chen H; Pan H; Liu W; Yi H; Tang S
    J Clin Pharm Ther; 2020 Aug; 45(4):638-645. PubMed ID: 32259340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
    Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
    J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.
    Tang SW; Lv XZ; Chen R; Wu SS; Yang ZR; Chen DF; Zhan SY
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):326-32. PubMed ID: 23469989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Sun F; Chen Y; Xiang Y; Zhan S
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
    Bai H; Wu T; Jiao L; Wu Q; Zhao Z; Song J; Liu T; Lv Y; Lu X; Ying B
    J Clin Pharmacol; 2020 Mar; 60(3):361-368. PubMed ID: 31648372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antituberculosis agents.
    Goldberger MJ
    Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.
    Wu S; Wang YJ; Tang X; Wang Y; Wu J; Ji G; Zhang M; Chen G; Liu Q; Sandford AJ; He JQ
    PLoS One; 2016; 11(6):e0157478. PubMed ID: 27281183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Analysis of DNA Methylation and Antituberculosis Drug-Induced Liver Injury in the Han Chinese Population.
    Huai C; Wei Y; Li M; Zhang X; Wu H; Qiu X; Shen L; Chen L; Zhou W; Zhang N; Zhu G; Zhang Y; Zhang Z; He L; Qin S
    Clin Pharmacol Ther; 2019 Dec; 106(6):1389-1397. PubMed ID: 31247120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
    Araujo-Mariz C; Militão de Albuquerque MFP; Lopes EP; Ximenes RAA; Lacerda HR; Miranda-Filho DB; Lustosa-Martins BB; Pastor AFP; Acioli-Santos B
    Ann Hepatol; 2020; 19(2):153-160. PubMed ID: 31734174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
    Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
    J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment].
    Chen R; Wang J; Tang SW; Lyu XZ; Zhang Y; Wu SS; Xia YY; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):925-9. PubMed ID: 27453098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.
    Nanashima K; Mawatari T; Tahara N; Higuchi N; Nakaura A; Inamine T; Kondo S; Yanagihara K; Fukushima K; Suyama N; Kohno S; Tsukamoto K
    Tuberculosis (Edinb); 2012 May; 92(3):253-9. PubMed ID: 22341855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.